Hospira Infringed 2 Valid Par Adrenalin Patents, Judge Says
A Delaware federal court has upheld two patents covering Par Pharmaceutical Inc.'s epinephrine product Adrenalin and determined that Hospira Inc.'s proposed generic version infringes them....To view the full article, register now.
Already a subscriber? Click here to view full article